October 3, 2016 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract surgery, announced today that it has acquired Moorfields Pharmaceuticals.
The acquisition closed September 30, 2016.
Rayner has acquired Moorfields Pharmaceuticals from Moorfields Eye Hospital NHS Foundation Trust for an undisclosed price, for the purpose of launching a specialist ophthalmic pharmaceuticals division that will be expanded across Rayner’s direct presence in Europe.
Members of the Moorfields Pharmaceuticals team will transfer to Rayner, however they will continue to be based in London, and will be shortly moving to a new office. Click here
for more information about Rayner Pharmaceuticals.